The Use and Benefit of Adjuvant Radiotherapy in Parathyroid Carcinoma: A National Cancer Database Analysis

被引:26
作者
Limberg, Jessica [1 ]
Stefanova, Dessislava [1 ]
Ullmann, Timothy M. [1 ]
Thiesmeyer, Jessica W. [1 ]
Bains, Sarina [1 ]
Beninato, Toni [1 ]
Zarnegar, Rasa [1 ]
Fahey, Thomas J., III [1 ]
Finnerty, Brendan M. [1 ]
机构
[1] NewYork Presbyterian Hosp, Weill Cornell Med Coll, Dept Surg, New York, NY 10033 USA
关键词
GUIDELINES; SURVIVAL; UPDATE;
D O I
10.1245/s10434-020-08825-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The routine use of external beam radiotherapy (EBRT) is not recommended for parathyroid carcinoma (PC). However, case series have demonstrated a potential benefit in preventing local recurrence with EBRT. We aimed to characterize the patient population treated with EBRT and identify any impact of EBRT on overall survival (OS) in parathyroid carcinoma. Methods Patients who underwent surgery for PC from 2004 to 2016 were identified from the National Cancer Database. Clinicopathologic variables and OS were compared between patients based on treatment with EBRT. Multivariable logistic and Cox regression models were performed with propensity scores and inverse-probability-weighting (IPW) adjustment to reduce treatment-selection bias in the OS analysis. Results A total of 885 patients met the inclusion criteria, with 126 (14.2%) undergoing EBRT. Demographics were similar between the two cohorts (EBRT vs. no EBRT). However, patients treated with EBRT had a higher frequency of regionally extensive disease, nodal metastases, and residual microscopic disease (allp < 0.05). On multivariable analysis, Black race, regional tumor extension, nodal metastasis, and treatment at an urban facility were independently associated with EBRT. The 5-year OS was 85.3% with a median follow-up of 60.8 months. EBRT was not associated with a difference in OS in crude, multivariable, or IPW models. More importantly, 10.5% of patients with completely resected localized disease (M0, N0 or Nx) underwent EBRT without a benefit in OS (p = 0.183). Conclusions EBRT is not associated with any survival benefit in the treatment of PC. Therefore, it may be overutilized, particularly in patients with localized disease and complete surgical resection.
引用
收藏
页码:502 / 511
页数:10
相关论文
共 25 条
  • [1] Parathyroid carcinoma
    Al-Kurd, Abbas
    Mekel, Michal
    Mazeh, Haggi
    [J]. SURGICAL ONCOLOGY-OXFORD, 2014, 23 (02): : 107 - 114
  • [2] Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center
    Asare, Elliot A.
    Silva-Figueroa, Angelica
    Hess, Kenneth R.
    Busaidy, Naifa
    Graham, Paul H.
    Grubbs, Elizabeth G.
    Lee, Jeffrey E.
    Williams, Michelle D.
    Perrier, Nancy D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (11) : 3593 - 3599
  • [3] Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)
    Asare, Elliot A.
    Sturgeon, Cord
    Winchester, David J.
    Liu, Lei
    Palis, Bryan
    Perrier, Nancy D.
    Evans, Douglas B.
    Winchester, David P.
    Wang, Tracy S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (12) : 3990 - 3995
  • [4] Parathyroid carcinoma: A 22-year experience
    Busaidy, NL
    Jimenez, C
    Habra, MA
    Schultz, PN
    El-Naggar, AK
    Clayman, GL
    Asper, JA
    Diaz, EM
    Evans, DB
    Gagel, RF
    Garden, A
    Hoff, AO
    Lee, JE
    Morrison, WH
    Rosenthal, DI
    Sherman, SI
    Sturgis, EM
    Waguespack, SG
    Weber, RS
    Wirfel, K
    Vassilopoulou-Sellin, R
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (08): : 716 - 726
  • [5] Parathyroid carcinoma - The Princess Margaret Hospital experience
    Chow, E
    Tsang, RW
    Brierley, JD
    Filice, S
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (03): : 569 - 572
  • [6] Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years
    Christakis, Ioannis
    Silva, Angelica M.
    Williams, Michelle D.
    Garden, Adam
    Grubbs, Elizabeth G.
    Busaidy, Naifa L.
    Lee, Jeffrey E.
    Perrier, Nancy D.
    Zafereo, Mark
    [J]. PRACTICAL RADIATION ONCOLOGY, 2017, 7 (06) : E463 - E470
  • [7] Current concepts in parathyroid carcinoma: a single Centre experience
    Ferraro, Valentina
    Sgaramella, Lucia Ilaria
    Di Meo, Giovanna
    Prete, Francesco Paolo
    Logoluso, Francesco
    Minerva, Francesco
    Noviello, Marica
    Renzulli, Giuseppina
    Gurrado, Angela
    Testini, Mario
    [J]. BMC ENDOCRINE DISORDERS, 2019, 19
  • [8] Parathyroid Carcinoma
    Givi, B.
    Shah, J. P.
    [J]. CLINICAL ONCOLOGY, 2010, 22 (06) : 498 - 507
  • [9] Greene FL., 2017, AJCC CANC STAGING MA, V8th, P1032
  • [10] Parathyroid Carcinoma: A 43-Year Outcome and Survival Analysis
    Harari, Avital
    Waring, Avantika
    Fernandez-Ranvier, Gustavo
    Hwang, Jimmy
    Suh, Insoo
    Mitmaker, Elliot
    Shen, Wen
    Gosnell, Jessica
    Duh, Quan-Yang
    Clark, Orlo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (12) : 3679 - 3686